Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Technion Research & Development Foundation Ltd

Hugo Gottlieb

David Lerner

Yaacov Herzig

Victor Piryatinsky

Istvan Miskolczi

Bronka Cohen

Dalia Pinkert

Marta Weinstock-Rosin

A method for treating an individual who has been identified as having Alzheimer's disease by administering orally to the individual a therapeutically effective amount of ladostigil or a pharmaceutically active salt thereof, wherein the therapeutically effective amount is 70 mg per day, 140 mg per day, or 200 mg per day. Also, a unit dosage form of ladostigil or a pharmaceutically active salt thereof in an amount of 50 mg, 70 mg, 80 mg or 100 mg.

Propargylated aminoindans, processes for preparation, and uses thereof

This invention provides compounds having the structure: 

Growing community of inventors

Rehovot, Israel

Hugo Gottlieb